Oscar Health (OSCR) Reports Earnings Tomorrow: What To Expect

Health insurance company Oscar Health (NYSE:OSCR) will be reporting results this Thursday morning. Here’s what investors should know.

Oscar Health missed analysts’ revenue expectations by 3.5% last quarter, reporting revenues of $2.86 billion, up 29% year on year. It was a disappointing quarter for the company, with a significant miss of analysts’ revenue estimates and a significant miss of analysts’ EPS estimates.

Is Oscar Health a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Oscar Health’s revenue to grow 27.4% year on year to $3.09 billion, slowing from the 68.3% increase it recorded in the same quarter last year. Adjusted loss is expected to come in at -$0.58 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Oscar Health has missed Wall Street’s revenue estimates four times over the last two years.

Looking at Oscar Health’s peers in the health insurance providers segment, some have already reported their Q3 results, giving us a hint as to what we can expect. CVS Health delivered year-on-year revenue growth of 7.8%, beating analysts’ expectations by 4.1%, and Centene reported revenues up 18.2%, topping estimates by 3.7%. CVS Health traded down 6.7% following the results while Centene was up 5.5%.

Read our full analysis of CVS Health’s results here and Centene’s results here.

Investors in the health insurance providers segment have had steady hands going into earnings, with share prices flat over the last month. Oscar Health is down 23.8% during the same time and is heading into earnings with an average analyst price target of $12.38 (compared to the current share price of $17.00).

P.S. STOP buying the AI stocks everyone’s talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.